Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Zimmer Biomet price target raised to $153 from $146 at SVB Leerink » 09:35
08/05/20
08/05
09:35
08/05/20
09:35
ZBH

Zimmer Biomet

/

+

SVB Leerink analyst…

SVB Leerink analyst Richard Newitter raised the firm's price target on Zimmer Biomet to $153 from $146 after the company delivered a "substantial" Q2 and EPS beat. The analyst believes Zimmer is dislocated from its post-COVID/normalized revenue/profit growth potential and a stock that investors will eventually come back to once the other side of COVID starts to come into clearer focus. He keeps an Outperform rating on the shares.

ShowHide Related Items >><<
ZBH Zimmer Biomet
/

+

ZBH Zimmer Biomet
/

+

08/05/20 Oppenheimer
Zimmer Biomet price target raised to $150 from $138 at Oppenheimer
08/05/20 Citi
Zimmer Biomet price target raised to $155 from $140 at Citi
08/04/20 Piper Sandler
Zimmer Biomet delivers Q2 beat off 'depressed' expectations, says Piper Sandler
07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
ZBH Zimmer Biomet
/

+

Recommendations
Zimmer Biomet price target raised to $150 from $138 at Oppenheimer » 07:33
08/05/20
08/05
07:33
08/05/20
07:33
ZBH

Zimmer Biomet

$130.50 /

-5.29 (-3.90%)

Oppenheimer analyst…

Oppenheimer analyst Steven Lichtman raised the firm's price target on Zimmer Biomet to $150 from $138 and keeps an Outperform rating on the shares. The analyst notes that Zimmer's Q2 results came in well above estimates, led by a steeper than expected recovery from COVID-19 headwinds. Lichtman sees upside drivers from M&A and from Rosa launches in hips and spine.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$130.50 /

-5.29 (-3.90%)

ZBH Zimmer Biomet
$130.50 /

-5.29 (-3.90%)

08/05/20 Citi
Zimmer Biomet price target raised to $155 from $140 at Citi
08/04/20 Piper Sandler
Zimmer Biomet delivers Q2 beat off 'depressed' expectations, says Piper Sandler
07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
ZBH Zimmer Biomet
$130.50 /

-5.29 (-3.90%)

Recommendations
Zimmer Biomet price target raised to $155 from $140 at Citi » 06:26
08/05/20
08/05
06:26
08/05/20
06:26
ZBH

Zimmer Biomet

$130.50 /

-5.29 (-3.90%)

Citi analyst Joanne…

Citi analyst Joanne Wuensch raised the firm's price target on Zimmer Biomet to $155 from $140 and reiterates a Buy rating on the shares. The company's Q2 results reflect not only its fundamental turnaround but the COVID-19 recovery, Wuensch tells investors in a research note.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$130.50 /

-5.29 (-3.90%)

ZBH Zimmer Biomet
$130.50 /

-5.29 (-3.90%)

08/04/20 Piper Sandler
Zimmer Biomet delivers Q2 beat off 'depressed' expectations, says Piper Sandler
07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
ZBH Zimmer Biomet
$130.50 /

-5.29 (-3.90%)

Recommendations
Zimmer Biomet delivers Q2 beat off 'depressed' expectations, says Piper Sandler » 14:27
08/04/20
08/04
14:27
08/04/20
14:27
ZBH

Zimmer Biomet

$130.75 /

-5.04 (-3.71%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $160 price target on Zimmer Biomet after the company delivered a "significant" Q2 earnings beat off "depressed" expectations. O'Brien said that the pace of recovery is ahead of expectations, and that the underlying dynamics within the company's key knee franchise are trending "favorably" despite the impact of COVID-19. The analyst added that anticipates portfolio management from the company either in the form of divestitures or acquisitions, and he continues to see upside to shares from these levels.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$130.75 /

-5.04 (-3.71%)

ZBH Zimmer Biomet
$130.75 /

-5.04 (-3.71%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$130.75 /

-5.04 (-3.71%)

Hot Stocks
Zimmer Biomet saw incremental improvement in May, June » 06:36
08/04/20
08/04
06:36
08/04/20
06:36
ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

Zimmer Biomet said in its…

Zimmer Biomet said in its Q2 earnings release, "Second quarter performance was negatively impacted by COVID-19, which reached a pandemic level in March and has resulted in a global decline in elective procedure volumes. The deepest decline in those procedures to-date was seen by the Company in April 2020, with incremental improvement in May and June."

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

Earnings
Zimmer Biomet not providing FY20 guidance due to COVID-19 » 06:34
08/04/20
08/04
06:34
08/04/20
06:34
ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

Zimmer Biomet said in its…

Zimmer Biomet said in its Q2 earnings release, "While Zimmer Biomet saw encouraging recovery in elective procedures during the second quarter, there continues to be uncertainty around the scope and duration of COVID-19 and its ongoing impact. Therefore, the Company is currently unable to quantify the expected impact on its results of operations, financial condition and cash flows, which could be material, for 2020 and is not providing full-year financial guidance at this time."

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

Earnings
Zimmer Biomet reports Q2 adj. EPS 5c, consensus (73c) » 06:33
08/04/20
08/04
06:33
08/04/20
06:33
ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

Reports Q2 revenue…

Reports Q2 revenue $1.23B, consensus $909.41M. "While we are encouraged by our operational performance and the stronger than expected recovery of elective procedures in the second quarter, the impact of COVID-19 is still significant and remains very fluid," said Bryan Hanson, President and CEO of Zimmer Biomet. "Even in this time of ongoing challenge and uncertainty, we continue to reshape and evolve Zimmer Biomet for greater value and are investing aggressively in our primary growth initiatives and innovative R&D programs to better position us for growth over the long term. I am so proud of our global team for the support we continue to provide healthcare professionals and patients every day and our ongoing commitment to the ZB mission to better the lives of people around the world."

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
08/03/20
08/03
20:25
08/03/20
20:25
FIS

FIS

$149.04 /

+2.73 (+1.87%)

, EXC

Exelon

$37.99 /

-0.61 (-1.58%)

, EMR

Emerson

$62.81 /

+0.78 (+1.26%)

, KKR

KKR

$35.80 /

+0.42 (+1.19%)

, ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

, TDG

TransDigm

$435.74 /

+4.05 (+0.94%)

, INCY

Incyte

$101.84 /

+3.08 (+3.12%)

, AME

Ametek

$95.00 /

+1.75 (+1.88%)

, WMG

Warner Music

$30.02 /

-0.165 (-0.55%)

, EXPD

Expeditors

$85.82 /

+1.31 (+1.55%)

, HSIC

Henry Schein

$70.90 /

+2.18 (+3.17%)

, WRK

WestRock

$27.86 /

+1.02 (+3.80%)

, IPHI

Inphi

$135.11 /

+4.515 (+3.46%)

, ARMK

Aramark

$20.95 /

-0.175 (-0.83%)

, RL

Ralph Lauren

$69.59 /

-1.83 (-2.56%)

, SPR

Spirit AeroSystems

$19.50 /

-0.05 (-0.26%)

, CNK

Cinemark

$11.88 /

+0.045 (+0.38%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include FIS (FIS), consensus $1.09... Exelon (EXC), consensus 43c... Emerson Electric (EMR), consensus 60c... KKR (KKR), consensus 36c... Zimmer Biomet (ZBH), consensus (73c)... TransDigm (TDG), consensus 94c... Incyte (INCY), consensus 88c... AMETEK (AME), consensus 72c... Warner Music (WMG), consensus 4c... Expeditors (EXPD), consensus 71c... Henry Schein (HSIC), consensus (11c)... WestRock (WRK), consensus 48c... Inphi (IPHI), consensus 65c... Aramark (ARMK), consensus (68c)... Ralph Lauren (RL), consensus ($1.72)... Spirit AeroSystems (SPR), consensus ($1.32)... Cinemark (CNK), consensus ($1.62).

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

WRK WestRock
$27.86 /

+1.02 (+3.80%)

WMG Warner Music
$30.02 /

-0.165 (-0.55%)

TDG TransDigm
$435.74 /

+4.05 (+0.94%)

SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

RL Ralph Lauren
$69.59 /

-1.83 (-2.56%)

KKR KKR
$35.80 /

+0.42 (+1.19%)

IPHI Inphi
$135.11 /

+4.515 (+3.46%)

INCY Incyte
$101.84 /

+3.08 (+3.12%)

HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

FIS FIS
$149.04 /

+2.73 (+1.87%)

EXPD Expeditors
$85.82 /

+1.31 (+1.55%)

EXC Exelon
$37.99 /

-0.61 (-1.58%)

EMR Emerson
$62.81 /

+0.78 (+1.26%)

CNK Cinemark
$11.88 /

+0.045 (+0.38%)

ARMK Aramark
$20.95 /

-0.175 (-0.83%)

AME Ametek
$95.00 /

+1.75 (+1.88%)

FIS FIS
$149.04 /

+2.73 (+1.87%)

08/03/20 KeyBanc
FIS price target raised to $165 from $140 at KeyBanc
07/22/20 Barclays
Fiserv shares undervalued after 'clearing event,' says Barclays
07/20/20 Stephens
FIS price target raised to $164 from $150 at Stephens
07/14/20 Argus
FIS initiated with a Buy at Argus
EXC Exelon
$37.99 /

-0.61 (-1.58%)

07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Mizuho
Exelon downgraded to Underperform from Neutral at Mizuho
07/21/20 BofA
Exelon downgraded to Neutral from Buy at BofA
05/20/20 Seaport Global
Seaport Global starts power and competitive retail sector with positive outlook
EMR Emerson
$62.81 /

+0.78 (+1.26%)

07/14/20 Deutsche Bank
Emerson downgraded to Hold from Buy at Deutsche Bank
04/22/20 Argus
Emerson upgraded to Buy from Hold at Argus
04/22/20 Argus
Emerson upgraded to Buy from Hold at Argus
03/31/20 JPMorgan
Rockwell, GE least favored Multi-Industry names at JPMorgan
KKR KKR
$35.80 /

+0.42 (+1.19%)

07/09/20 Keefe Bruyette
KKR price target raised to $41 from $34 at Keefe Bruyette
06/29/20 Wells Fargo
CyrusOne CEO appointment could reignite sale speculation, says Wells Fargo
06/17/20 Piper Sandler
KKR initiated with an Overweight at Piper Sandler
05/07/20 Oppenheimer
KKR price target lowered to $34 from $41 at Oppenheimer
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
TDG TransDigm
$435.74 /

+4.05 (+0.94%)

07/15/20 Truist
SunTrust downgrades select commercial aviation supply stocks
07/15/20 Truist
TransDigm downgraded to Hold from Buy at SunTrust
06/23/20 Susquehanna
TransDigm challenged near term, Susquehanna starts with Neutral
06/23/20 Susquehanna
TransDigm initiated with a Neutral at Susquehanna
INCY Incyte
$101.84 /

+3.08 (+3.12%)

08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
07/23/20 Stifel
Incyte REACH3 'nice incremental surprise,' not narrative-changing, says Stifel
07/23/20 Piper Sandler
Piper says Incyte cements 'all-around win for Jakafi' with REACH3 results
AME Ametek
$95.00 /

+1.75 (+1.88%)

07/13/20 Morgan Stanley
Illinois Tool Works downgraded to Underweight at Morgan Stanley
06/12/20 Oppenheimer
Oppenheimer downgrades Ametek to Perform with end markets softening
06/11/20 Oppenheimer
Ametek downgraded to Perform from Outperform at Oppenheimer
05/26/20 BofA
Ametek upgraded to Buy on best-in-class execution at BofA
WMG Warner Music
$30.02 /

-0.165 (-0.55%)

06/30/20
Fly Intel: Top five analyst initiations
06/30/20 Loop Capital
Warner Music initiated with a Hold at Loop Capital
06/30/20 Citi
Warner Music initiated with a Neutral, $33 target at Citi
06/30/20 Citi
Warner Music initiated with a Neutral at Citi
EXPD Expeditors
$85.82 /

+1.31 (+1.55%)

07/07/20 Wolfe Research
Expeditors downgraded to Underperform from Peer Perform at Wolfe Research
06/23/20 Baird
Expeditors elevated to Fresh Pick at Baird
03/23/20 Morgan Stanley
Morgan Stanley upgrades Freight Transport industry to In-Line, raises 3 stocks
10/02/19 Barclays
Barclays downgrades Expeditors on call to lessen transport exposure
HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

05/06/20 Barrington
Henry Schein downgraded to Market Perform from Outperform at Barrington
04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
WRK WestRock
$27.86 /

+1.02 (+3.80%)

07/16/20 BofA
Packaging Corp. upgraded to Buy after better than expected data at BofA
07/16/20 BofA
International Paper upgraded to Buy after better than expected data at BofA
06/15/20 Morgan Stanley
WestRock initiated with an Equal Weight at Morgan Stanley
05/26/20 Deutsche Bank
WestRock price target lowered to $34 from $42 at Deutsche Bank
IPHI Inphi
$135.11 /

+4.515 (+3.46%)

07/23/20 Loop Capital
Inphi initiated with a Buy at Loop Capital
07/17/20 Deutsche Bank
Inphi price target raised to $140 from $115 at Deutsche Bank
07/07/20 Needham
Inphi price target raised to $135 from $122.50 at Needham
06/25/20 JPMorgan
Inphi datacenter business can grow 30% annually, says JPMorgan
ARMK Aramark
$20.95 /

-0.175 (-0.83%)

07/16/20
Fly Intel: Top five analyst downgrades
07/16/20 RBC Capital
Aramark downgraded to Sector Perform from Outperform at RBC Capital
07/16/20 RBC Capital
Aramark downgraded to Sector Perform from Outperform at RBC Capital
06/10/20 Bernstein
Aramark downgraded to Market Perform from Outperform at Bernstein
RL Ralph Lauren
$69.59 /

-1.83 (-2.56%)

07/20/20 Wells Fargo
Ralph Lauren price target lowered to $90 from $100 at Wells Fargo
06/22/20 RBC Capital
Ralph Lauren price target raised to $82 from $77 at RBC Capital
05/28/20 Needham
Ralph Lauren price target raised to $90 from $80 at Needham
05/28/20 Credit Suisse
Ralph Lauren price target raised to $89 from $82 at Credit Suisse
SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
07/08/20 Bernstein
Spirit AeroSystems downgraded to Market Perform from Outperform at Bernstein
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
06/23/20
Fly Intel: Top five analyst downgrades
CNK Cinemark
$11.88 /

+0.045 (+0.38%)

07/29/20 Wedbush
Cinemark price target lowered to $15 from $20 at Wedbush
07/15/20 Goldman Sachs
Cinemark initiated with a Neutral at Goldman Sachs
07/13/20 MKM Partners
MKM Partners lowers price targets in Cinema sector
06/29/20 Credit Suisse
Cinemark downgraded to Neutral from Outperform at Credit Suisse
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

WRK WestRock
$27.86 /

+1.02 (+3.80%)

TDG TransDigm
$435.74 /

+4.05 (+0.94%)

SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

RL Ralph Lauren
$69.59 /

-1.83 (-2.56%)

KKR KKR
$35.80 /

+0.42 (+1.19%)

IPHI Inphi
$135.11 /

+4.515 (+3.46%)

INCY Incyte
$101.84 /

+3.08 (+3.12%)

HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

FIS FIS
$149.04 /

+2.73 (+1.87%)

EXPD Expeditors
$85.82 /

+1.31 (+1.55%)

EXC Exelon
$37.99 /

-0.61 (-1.58%)

EMR Emerson
$62.81 /

+0.78 (+1.26%)

CNK Cinemark
$11.88 /

+0.045 (+0.38%)

ARMK Aramark
$20.95 /

-0.175 (-0.83%)

AME Ametek
$95.00 /

+1.75 (+1.88%)

  • 03
    Jun
WMG Warner Music
$30.02 /

-0.165 (-0.55%)

SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

KKR KKR
$35.80 /

+0.42 (+1.19%)

EMR Emerson
$62.81 /

+0.78 (+1.26%)

CNK Cinemark
$11.88 /

+0.045 (+0.38%)

WMG Warner Music
$30.02 /

-0.165 (-0.55%)

TDG TransDigm
$435.74 /

+4.05 (+0.94%)

SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

RL Ralph Lauren
$69.59 /

-1.83 (-2.56%)

KKR KKR
$35.80 /

+0.42 (+1.19%)

IPHI Inphi
$135.11 /

+4.515 (+3.46%)

INCY Incyte
$101.84 /

+3.08 (+3.12%)

HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

FIS FIS
$149.04 /

+2.73 (+1.87%)

CNK Cinemark
$11.88 /

+0.045 (+0.38%)

WMG Warner Music
$30.02 /

-0.165 (-0.55%)

TDG TransDigm
$435.74 /

+4.05 (+0.94%)

SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

RL Ralph Lauren
$69.59 /

-1.83 (-2.56%)

KKR KKR
$35.80 /

+0.42 (+1.19%)

INCY Incyte
$101.84 /

+3.08 (+3.12%)

FIS FIS
$149.04 /

+2.73 (+1.87%)

EXC Exelon
$37.99 /

-0.61 (-1.58%)

EMR Emerson
$62.81 /

+0.78 (+1.26%)

CNK Cinemark
$11.88 /

+0.045 (+0.38%)

Earnings
Notable companies reporting before tomorrow's open » 14:29
08/03/20
08/03
14:29
08/03/20
14:29
FIS

FIS

$148.79 /

+2.48 (+1.70%)

, EXC

Exelon

$38.03 /

-0.57 (-1.48%)

, EMR

Emerson

$63.40 /

+1.37 (+2.21%)

, KKR

KKR

$35.58 /

+0.2 (+0.57%)

, ZBH

Zimmer Biomet

$136.58 /

+1.73 (+1.28%)

, TDG

TransDigm

$436.54 /

+4.85 (+1.12%)

, INCY

Incyte

$101.30 /

+2.54 (+2.57%)

, AME

Ametek

$95.56 /

+2.31 (+2.48%)

, WMG

Warner Music

$30.02 /

-0.165 (-0.55%)

, EXPD

Expeditors

$85.51 /

+1 (+1.18%)

, HSIC

Henry Schein

$70.25 /

+1.53 (+2.23%)

, WRK

WestRock

$27.94 /

+1.1 (+4.10%)

, IPHI

Inphi

$135.12 /

+4.53 (+3.47%)

, ARMK

Aramark

$20.84 /

-0.285 (-1.35%)

, RL

Ralph Lauren

$69.34 /

-2.08 (-2.91%)

, SPR

Spirit AeroSystems

$19.41 /

-0.14 (-0.72%)

, CNK

Cinemark

$11.97 /

+0.14 (+1.18%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include FIS (FIS), consensus $1.09... Exelon (EXC), consensus 43c... Emerson Electric (EMR), consensus 60c... KKR (KKR), consensus 36c... Zimmer Biomet (ZBH), consensus (73c)... TransDigm (TDG), consensus 94c... Incyte (INCY), consensus 88c... AMETEK (AME), consensus 72c... Warner Music (WMG), consensus 4c... Expeditors (EXPD), consensus 71c... Henry Schein (HSIC), consensus (11c)... WestRock (WRK), consensus 48c... Inphi (IPHI), consensus 65c... Aramark (ARMK), consensus (68c)... Ralph Lauren (RL), consensus ($1.72)... Spirit AeroSystems (SPR), consensus ($1.32)... Cinemark (CNK), consensus ($1.62).

ShowHide Related Items >><<
ZBH Zimmer Biomet
$136.58 /

+1.73 (+1.28%)

WRK WestRock
$27.94 /

+1.1 (+4.10%)

WMG Warner Music
$30.02 /

-0.165 (-0.55%)

TDG TransDigm
$436.54 /

+4.85 (+1.12%)

SPR Spirit AeroSystems
$19.41 /

-0.14 (-0.72%)

RL Ralph Lauren
$69.34 /

-2.08 (-2.91%)

KKR KKR
$35.58 /

+0.2 (+0.57%)

IPHI Inphi
$135.12 /

+4.53 (+3.47%)

INCY Incyte
$101.30 /

+2.54 (+2.57%)

HSIC Henry Schein
$70.25 /

+1.53 (+2.23%)

FIS FIS
$148.79 /

+2.48 (+1.70%)

EXPD Expeditors
$85.51 /

+1 (+1.18%)

EXC Exelon
$38.03 /

-0.57 (-1.48%)

EMR Emerson
$63.40 /

+1.37 (+2.21%)

CNK Cinemark
$11.97 /

+0.14 (+1.18%)

ARMK Aramark
$20.84 /

-0.285 (-1.35%)

AME Ametek
$95.56 /

+2.31 (+2.48%)

FIS FIS
$148.79 /

+2.48 (+1.70%)

08/03/20 KeyBanc
FIS price target raised to $165 from $140 at KeyBanc
07/22/20 Barclays
Fiserv shares undervalued after 'clearing event,' says Barclays
07/20/20 Stephens
FIS price target raised to $164 from $150 at Stephens
07/14/20 Argus
FIS initiated with a Buy at Argus
EXC Exelon
$38.03 /

-0.57 (-1.48%)

07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Mizuho
Exelon downgraded to Underperform from Neutral at Mizuho
07/21/20 BofA
Exelon downgraded to Neutral from Buy at BofA
05/20/20 Seaport Global
Seaport Global starts power and competitive retail sector with positive outlook
EMR Emerson
$63.40 /

+1.37 (+2.21%)

07/14/20 Deutsche Bank
Emerson downgraded to Hold from Buy at Deutsche Bank
04/22/20 Argus
Emerson upgraded to Buy from Hold at Argus
04/22/20 Argus
Emerson upgraded to Buy from Hold at Argus
03/31/20 JPMorgan
Rockwell, GE least favored Multi-Industry names at JPMorgan
KKR KKR
$35.58 /

+0.2 (+0.57%)

07/09/20 Keefe Bruyette
KKR price target raised to $41 from $34 at Keefe Bruyette
06/29/20 Wells Fargo
CyrusOne CEO appointment could reignite sale speculation, says Wells Fargo
06/17/20 Piper Sandler
KKR initiated with an Overweight at Piper Sandler
05/07/20 Oppenheimer
KKR price target lowered to $34 from $41 at Oppenheimer
ZBH Zimmer Biomet
$136.58 /

+1.73 (+1.28%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
TDG TransDigm
$436.54 /

+4.85 (+1.12%)

07/15/20 Truist
SunTrust downgrades select commercial aviation supply stocks
07/15/20 Truist
TransDigm downgraded to Hold from Buy at SunTrust
06/23/20 Susquehanna
TransDigm challenged near term, Susquehanna starts with Neutral
06/23/20 Susquehanna
TransDigm initiated with a Neutral at Susquehanna
INCY Incyte
$101.30 /

+2.54 (+2.57%)

08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
07/23/20 Stifel
Incyte REACH3 'nice incremental surprise,' not narrative-changing, says Stifel
07/23/20 Piper Sandler
Piper says Incyte cements 'all-around win for Jakafi' with REACH3 results
AME Ametek
$95.56 /

+2.31 (+2.48%)

07/13/20 Morgan Stanley
Illinois Tool Works downgraded to Underweight at Morgan Stanley
06/12/20 Oppenheimer
Oppenheimer downgrades Ametek to Perform with end markets softening
06/11/20 Oppenheimer
Ametek downgraded to Perform from Outperform at Oppenheimer
05/26/20 BofA
Ametek upgraded to Buy on best-in-class execution at BofA
WMG Warner Music
$30.02 /

-0.165 (-0.55%)

06/30/20
Fly Intel: Top five analyst initiations
06/30/20 Loop Capital
Warner Music initiated with a Hold at Loop Capital
06/30/20 Citi
Warner Music initiated with a Neutral, $33 target at Citi
06/30/20 Citi
Warner Music initiated with a Neutral at Citi
EXPD Expeditors
$85.51 /

+1 (+1.18%)

07/07/20 Wolfe Research
Expeditors downgraded to Underperform from Peer Perform at Wolfe Research
06/23/20 Baird
Expeditors elevated to Fresh Pick at Baird
03/23/20 Morgan Stanley
Morgan Stanley upgrades Freight Transport industry to In-Line, raises 3 stocks
10/02/19 Barclays
Barclays downgrades Expeditors on call to lessen transport exposure
HSIC Henry Schein
$70.25 /

+1.53 (+2.23%)

05/06/20 Barrington
Henry Schein downgraded to Market Perform from Outperform at Barrington
04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
WRK WestRock
$27.94 /

+1.1 (+4.10%)

07/16/20 BofA
Packaging Corp. upgraded to Buy after better than expected data at BofA
07/16/20 BofA
International Paper upgraded to Buy after better than expected data at BofA
06/15/20 Morgan Stanley
WestRock initiated with an Equal Weight at Morgan Stanley
05/26/20 Deutsche Bank
WestRock price target lowered to $34 from $42 at Deutsche Bank
IPHI Inphi
$135.12 /

+4.53 (+3.47%)

07/23/20 Loop Capital
Inphi initiated with a Buy at Loop Capital
07/17/20 Deutsche Bank
Inphi price target raised to $140 from $115 at Deutsche Bank
07/07/20 Needham
Inphi price target raised to $135 from $122.50 at Needham
06/25/20 JPMorgan
Inphi datacenter business can grow 30% annually, says JPMorgan
ARMK Aramark
$20.84 /

-0.285 (-1.35%)

07/16/20
Fly Intel: Top five analyst downgrades
07/16/20 RBC Capital
Aramark downgraded to Sector Perform from Outperform at RBC Capital
07/16/20 RBC Capital
Aramark downgraded to Sector Perform from Outperform at RBC Capital
06/10/20 Bernstein
Aramark downgraded to Market Perform from Outperform at Bernstein
RL Ralph Lauren
$69.34 /

-2.08 (-2.91%)

07/20/20 Wells Fargo
Ralph Lauren price target lowered to $90 from $100 at Wells Fargo
06/22/20 RBC Capital
Ralph Lauren price target raised to $82 from $77 at RBC Capital
05/28/20 Needham
Ralph Lauren price target raised to $90 from $80 at Needham
05/28/20 Credit Suisse
Ralph Lauren price target raised to $89 from $82 at Credit Suisse
SPR Spirit AeroSystems
$19.41 /

-0.14 (-0.72%)

07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
07/08/20 Bernstein
Spirit AeroSystems downgraded to Market Perform from Outperform at Bernstein
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
06/23/20
Fly Intel: Top five analyst downgrades
CNK Cinemark
$11.97 /

+0.14 (+1.18%)

07/29/20 Wedbush
Cinemark price target lowered to $15 from $20 at Wedbush
07/15/20 Goldman Sachs
Cinemark initiated with a Neutral at Goldman Sachs
07/13/20 MKM Partners
MKM Partners lowers price targets in Cinema sector
06/29/20 Credit Suisse
Cinemark downgraded to Neutral from Outperform at Credit Suisse
ZBH Zimmer Biomet
$136.58 /

+1.73 (+1.28%)

WRK WestRock
$27.94 /

+1.1 (+4.10%)

TDG TransDigm
$436.54 /

+4.85 (+1.12%)

SPR Spirit AeroSystems
$19.41 /

-0.14 (-0.72%)

RL Ralph Lauren
$69.34 /

-2.08 (-2.91%)

KKR KKR
$35.58 /

+0.2 (+0.57%)

IPHI Inphi
$135.12 /

+4.53 (+3.47%)

INCY Incyte
$101.30 /

+2.54 (+2.57%)

HSIC Henry Schein
$70.25 /

+1.53 (+2.23%)

FIS FIS
$148.79 /

+2.48 (+1.70%)

EXPD Expeditors
$85.51 /

+1 (+1.18%)

EXC Exelon
$38.03 /

-0.57 (-1.48%)

EMR Emerson
$63.40 /

+1.37 (+2.21%)

CNK Cinemark
$11.97 /

+0.14 (+1.18%)

ARMK Aramark
$20.84 /

-0.285 (-1.35%)

AME Ametek
$95.56 /

+2.31 (+2.48%)

  • 03
    Jun
WMG Warner Music
$30.02 /

-0.165 (-0.55%)

SPR Spirit AeroSystems
$19.41 /

-0.14 (-0.72%)

KKR KKR
$35.58 /

+0.2 (+0.57%)

EMR Emerson
$63.40 /

+1.37 (+2.21%)

CNK Cinemark
$11.97 /

+0.14 (+1.18%)

WMG Warner Music
$30.02 /

-0.165 (-0.55%)

TDG TransDigm
$436.54 /

+4.85 (+1.12%)

SPR Spirit AeroSystems
$19.41 /

-0.14 (-0.72%)

RL Ralph Lauren
$69.34 /

-2.08 (-2.91%)

KKR KKR
$35.58 /

+0.2 (+0.57%)

IPHI Inphi
$135.12 /

+4.53 (+3.47%)

INCY Incyte
$101.30 /

+2.54 (+2.57%)

HSIC Henry Schein
$70.25 /

+1.53 (+2.23%)

FIS FIS
$148.79 /

+2.48 (+1.70%)

CNK Cinemark
$11.97 /

+0.14 (+1.18%)

WMG Warner Music
$30.02 /

-0.165 (-0.55%)

TDG TransDigm
$436.54 /

+4.85 (+1.12%)

SPR Spirit AeroSystems
$19.41 /

-0.14 (-0.72%)

RL Ralph Lauren
$69.34 /

-2.08 (-2.91%)

KKR KKR
$35.58 /

+0.2 (+0.57%)

INCY Incyte
$101.30 /

+2.54 (+2.57%)

FIS FIS
$148.79 /

+2.48 (+1.70%)

EXC Exelon
$38.03 /

-0.57 (-1.48%)

EMR Emerson
$63.40 /

+1.37 (+2.21%)

CNK Cinemark
$11.97 /

+0.14 (+1.18%)

Recommendations
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright » 12:09
07/24/20
07/24
12:09
07/24/20
12:09
ACRX

AcelRx

$1.14 /

+0.01 (+0.88%)

, ZBH

Zimmer Biomet

$132.51 /

-0.22 (-0.17%)

After AcelRx (ACRX)…

After AcelRx (ACRX) announced a distribution agreement with Zimmer Biomet Dental (ZBH) for the exclusive right to promote, market, sell, and distribute the former's Dsuvia tablet for dental and oral surgery procedures, H.C. Wainwright analyst Ed Arce said he consider the arrangement as a "win-win." The dental/oral surgery market represents a valuable market that was previously hard to reach by AcelRx, and ZB Dental now has a safe, rapid, and convenient pain solution in its portfolio, said the analyst. Arce affirms a Buy rating and $7 price target on AcelRx following what he views as an agreement with "minimal risk" and "no significant downside."

ShowHide Related Items >><<
ZBH Zimmer Biomet
$132.51 /

-0.22 (-0.17%)

ACRX AcelRx
$1.14 /

+0.01 (+0.88%)

ACRX AcelRx
$1.14 /

+0.01 (+0.88%)

07/20/20
Fly Intel: Top five analyst downgrades
07/20/20 Credit Suisse
AcelRx downgraded to Underperform on 'mounting challenges' at Credit Suisse
07/20/20 Credit Suisse
AcelRx downgraded to Underperform from Neutral at Credit Suisse
05/07/20 Gabelli
Tetraphase upgraded to Hold from Sell at Gabelli
ZBH Zimmer Biomet
$132.51 /

-0.22 (-0.17%)

05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
05/12/20 Wells Fargo
Zimmer Biomet price target raised to $132 from $124 at Wells Fargo
ZBH Zimmer Biomet
$132.51 /

-0.22 (-0.17%)

ACRX AcelRx
$1.14 /

+0.01 (+0.88%)

ACRX AcelRx
$1.14 /

+0.01 (+0.88%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.